Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - SignPath Pharma, Inc. | Financial_Report.xls |
| EX-3.9 - CERTIFICATE OF DESIGNATION, PREFERENCES AND RIGHTS OF SERIES D CONVERTIBLE PREFERRED STOCK - SignPath Pharma, Inc. | signpathexh39.htm |
| S-1/A - SIGNPATH PHARMA INC. S-1/A4 - SignPath Pharma, Inc. | signpath.htm |
| EX-5.1 - OPINION OF DAVIDOFF HUTCHER & CITRON LLP - SignPath Pharma, Inc. | signpathexh51.htm |
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use, in Amendment No. 4 to the registration statement on Form S-1 of SignPath Pharma Inc. (a development stage company), of our report dated March 31, 2014 on our audit of the financial statements of SignPath Pharma Inc. as of December 31, 2013 and 2012, and the related statements of operations, stockholders’ equity (deficit) and cash flows for the years then ended. The financial statements for the period from inception (May 15, 2006) to December 31, 2007, were audited by other auditors whose report expressed an unqualified opinion on those statements, and the reference to us under the caption “Experts.”
/s/ M&K CPAS, PLLC
Houston, Texas
December 12, 2014